ES2173198T3 - Derivados de acido propenoico sustituidos con heterociclos, como antagonistas de nmda. - Google Patents

Derivados de acido propenoico sustituidos con heterociclos, como antagonistas de nmda.

Info

Publication number
ES2173198T3
ES2173198T3 ES95933902T ES95933902T ES2173198T3 ES 2173198 T3 ES2173198 T3 ES 2173198T3 ES 95933902 T ES95933902 T ES 95933902T ES 95933902 T ES95933902 T ES 95933902T ES 2173198 T3 ES2173198 T3 ES 2173198T3
Authority
ES
Spain
Prior art keywords
derivatives
propenoic acid
heterocicles
nmda antagonists
acid replaced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95933902T
Other languages
English (en)
Inventor
Boyd L Harrison
Philip L Nyce
Robert A Farr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Aventis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharmaceuticals Inc filed Critical Aventis Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2173198T3 publication Critical patent/ES2173198T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

SE DESCRIBEN DERIVADOS DE ACIDO PROPENOICO, SUSTITUIDOS EN POSICION 3 CON UN HETEROCICLO, DE FORMULA (I), DONDE G ES UN RADICAL ELEGIDO ENTRE EL GRUPO (A), (B) O (C). DICHOS DERIVADOS DE ACIDO PROPENOICO, SON UTILES COMO ANTAGONISTAS DE NMDA.
ES95933902T 1994-10-31 1995-09-21 Derivados de acido propenoico sustituidos con heterociclos, como antagonistas de nmda. Expired - Lifetime ES2173198T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08332016 US5563157B1 (en) 1994-10-31 1994-10-31 Heterocycle substituted propenoic acid derivatives and pharmaceutical compositions thereof

Publications (1)

Publication Number Publication Date
ES2173198T3 true ES2173198T3 (es) 2002-10-16

Family

ID=23296353

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95933902T Expired - Lifetime ES2173198T3 (es) 1994-10-31 1995-09-21 Derivados de acido propenoico sustituidos con heterociclos, como antagonistas de nmda.

Country Status (21)

Country Link
US (3) US5563157B1 (es)
EP (1) EP0790994B1 (es)
JP (1) JP3934678B2 (es)
KR (1) KR100401138B1 (es)
CN (1) CN1068001C (es)
AT (1) ATE217307T1 (es)
AU (1) AU696423B2 (es)
CA (1) CA2202992C (es)
DE (1) DE69526668T2 (es)
DK (1) DK0790994T3 (es)
ES (1) ES2173198T3 (es)
FI (1) FI971831A0 (es)
HU (1) HU222372B1 (es)
IL (1) IL115791A (es)
MX (1) MX9703146A (es)
NO (1) NO313197B1 (es)
NZ (1) NZ293842A (es)
PT (1) PT790994E (es)
TW (1) TW336232B (es)
WO (1) WO1996013501A1 (es)
ZA (1) ZA959046B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922752A (en) * 1997-06-11 1999-07-13 Hoechst Marion Roussell, Inc. NMDA (n-methyl-d-aspartate) antagonists
GB9902455D0 (en) * 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
JP2004529855A (ja) 2000-10-10 2004-09-30 スミスクライン ビーチャム コーポレーション 置換インドール類、そのような置換インドール類を含む医薬組成物及びＰＰＡＲ−γ結合剤としてのそれらの使用
WO2002072542A2 (en) * 2001-03-08 2002-09-19 Emory University Ph-dependent nmda receptor antagonists
CN103058957A (zh) 2007-06-29 2013-04-24 埃莫里大学 用于神经保护的nmda受体拮抗剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0539503B1 (en) * 1990-07-16 1996-04-03 Merrell Dow Pharmaceuticals Inc. Excitatory amino acid antagonists
JP3094450B2 (ja) * 1990-10-15 2000-10-03 アストラゼネカ・アクチエボラーグ 神経保護特性を有するピペリジン誘導体
US5284862A (en) * 1991-03-18 1994-02-08 Warner-Lambert Company Derivatives of 2-carboxyindoles having pharmaceutical activity
GB9208492D0 (en) * 1992-04-16 1992-06-03 Glaxo Spa Heterocyclic compounds
US5519048A (en) * 1993-05-27 1996-05-21 Merrell Pharmaceuticals Inc. 3-(indol-3-yl)-propenoic acid derivatives and pharmaceutical compositions thereof
CN1051302C (zh) * 1993-05-27 2000-04-12 默里尔药物公司 3－(吲哚－3－基)丙烯酸衍生物及其用作nmda拮抗剂

Also Published As

Publication number Publication date
US5981553A (en) 1999-11-09
FI971831L (fi) 1997-04-29
IL115791A (en) 2000-09-28
ZA959046B (en) 1996-05-17
NZ293842A (en) 1998-09-24
AU3638795A (en) 1996-05-23
DE69526668D1 (de) 2002-06-13
JP3934678B2 (ja) 2007-06-20
US6180786B1 (en) 2001-01-30
FI971831A7 (fi) 1997-04-29
US5563157B1 (en) 1999-02-02
NO971991L (no) 1997-04-29
JPH10508019A (ja) 1998-08-04
MX9703146A (es) 1997-06-28
CN1068001C (zh) 2001-07-04
WO1996013501A1 (en) 1996-05-09
AU696423B2 (en) 1998-09-10
CA2202992A1 (en) 1996-05-09
KR100401138B1 (ko) 2003-12-24
HUT77174A (hu) 1998-03-02
ATE217307T1 (de) 2002-05-15
US5563157A (en) 1996-10-08
DK0790994T3 (da) 2002-08-26
CA2202992C (en) 2003-05-13
DE69526668T2 (de) 2003-01-02
EP0790994A1 (en) 1997-08-27
IL115791A0 (en) 1996-01-19
HU222372B1 (hu) 2003-06-28
TW336232B (en) 1998-07-11
CN1161696A (zh) 1997-10-08
PT790994E (pt) 2002-08-30
FI971831A0 (fi) 1997-04-29
NO313197B1 (no) 2002-08-26
NO971991D0 (no) 1997-04-29
EP0790994B1 (en) 2002-05-08

Similar Documents

Publication Publication Date Title
NO178969C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte kinazolinoner
ES2078291T3 (es) Nuevos derivados de acido a-nor-esteroide-3-carboxilico.
ES2070660B1 (es) Un procedimiento para la preparacion de 2,5-damino-3-hidroxihexanos sustituidos, utiles como inhibidores de proteasas retrovirales.
YU164791A (sh) Nezasićene hidroksialkilhinolin kiseline
DE3775527D1 (de) 1,5-diphenylpyrazol-3-carbonsaeurederivate zum schuetzen von kulturpflanzen.
JPS5412381A (en) N-alkylpiperidine derivative
ES2079484T3 (es) Pasta estabilizada con acidos.
ES2066808T3 (es) Derivados de quinoleina, su produccion y uso.
ES2176456T3 (es) Procedimiento de preparacion de un compuesto inhibidor del vih proteasa.
MX17846A (es) Proceso para la preparacion de nuevos derivados de 9h purina.
ES2093099T3 (es) Preparacion de piperidinas sustituidas.
BG32850A3 (en) Method for obtaining of 6 a, 10 a- cis- hexahydrodibenzopyranols
ES2001703A6 (es) Procedimiento para la preparracion de derrrivados de acidos 2-(2-imidazolin -2-il)- piridin -3- carboxilicos.
ES8801806A1 (es) Procedimientopara la preparacion de derivados de 2-oxi-4h-3, 1-ebzoxazin-4-ona
FI893842A0 (fi) Menetelmä uuden antibiootin, mersasidiinin, valmistamiseksi
ATE55990T1 (de) Substituierte 4,6-alkoxypyridincarboxylatverbindungen.
SE9704272D0 (sv) Novel Compounds
ECSP941031A (es) Derivados de timosina alfa 1
TR200001080T2 (tr) 2 ile ikame edilmiş 1,2-Benisotiyazol türevleri ve bunların serrotonın antagonistleri
ES462643A1 (es) Procedimiento para la preparacion de compuestos antraquini- nicos.
EP0118564A4 (en) 4-amino-tetrahydro-2-naphthoic acid derivatives.
GR900100356A (el) Νέα παράγωγα 9α-υδροξυ-3-οξο4,24(25)-στιγμασταδιέν-26-οϊκού οξέος και μέ?οδος για την παρασκευή τους.
MX9703146A (es) Derivados de acido propenoico substituido con heterociclo como antagonistas de nmda.
DE3366279D1 (de) Substituted tetrahydropyridazino(1,6-a)benzimidazoles
ATE85185T1 (de) 1,4-naphthochinonderivate enthaltende rodentizide zusammensetzungen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 790994

Country of ref document: ES